Comparing Efficacy and Safety of CinnaGen Biosimilar Growth Hormone (CinnaTropin®) Versus Nordilet in Children With Idiopathic Growth Hormone Deficiency
Clinical trial NCT03223025 · COMPLETED
Trial details
- NCT number
- NCT03223025
- Sponsor
- Cinnagen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-09
- Primary completion
- 2017-02-04
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.